In AML with FLT3-ITD, investigators noted increased induction of cell cycle arrest and a shift in the splicing patterns toward a pro-apoptotic state due to reduced MCL1 following pladienolide treatment [33]. The gene discussed is FLT3; the disease is acute myeloid leukemia.